The FDA cleared Mariner Endosurgery's augmented reality surgical navigation system that provides an overlay similar to a heads-up display.

Roche teamed up with immuno-oncology competitor Merck to develop a pan-cancer diagnostic for its Keytruda therapy in mismatch repair deficiency.

Olympus pleaded guilty to not filing adverse event reports as required by the FDA for its duodenoscopes, agreeing to $85 million in fines and forfeiture.

The FDA cleared its first digital therapeutic for patients with opioid use disorder: an app by Pear Therapeutics to be used alongside medications.

10x Genomics is making moves into the emerging field of tissue genomics by buying Spatial Transcriptomics and its location-based mRNA analysis tools.

Luma Therapeutics launched its UV-based plaque psoriasis device, available through a dermatologist or Luma’s telehealth provider, HealthLens.

Merck KGaA has licensed a cloud-based artificial intelligence proteome screening platform from the Toronto-based Cyclica.

The new Apple Watch’s electrocardiogram capability has gone live, available as a free software update that allows for wrist-based ECGs on the go.